Dual-time-point positron emission tomography findings of benign mediastinal fluorine-18-fluorodeoxyglucose uptake in tuberculosis-endemic region

Indian Journal of Nuclear Medicine

Volumn 26, Issue 1, 2011, Pages 3-6

  Kim, Dae Weung ^a   Park, Soon Ah ^a   Kim, Chang Guhn ^a  

^a Wonkwang University School of Medicine   (South Korea)

Author keywords

Dual time point imaging; fluorine 18 fluorodeoxyglucose positron emission tomography computed tomography; mediastinal lymph node; tuberculosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; BREAST CANCER; CALCIFICATION; CLINICAL ARTICLE; DRUG UPTAKE; DUAL POINT POSITRON EMISSION TOMOGRAPHY; ESOPHAGUS CANCER; FEMALE; HUMAN; LUNG CANCER; LUNG NODULE; LUNG TUBERCULOSIS; MALE; MEDIASTINUM LYMPH NODE; METASTASIS; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; THORAX TUMOR;

EID: 80052888031     PISSN: 09723919     EISSN: 09740244     Source Type: Journal    
DOI: 10.4103/0972-3919.84586     Document Type: Article

References (15)

1. Kang WJ, Chung JK, So Y, Jeong JM, Lee DS, Lee MC. Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours. Eur J Nucl Med Mol Imaging 2004;31:202-7. (Pubitemid 38173695)
2. Shinya T, Rai K, Okumura Y, Fujiwara K, Matsuo K, Yonei T, et al. Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer. Clin Nucl Med 2009;34:216-21.
3. Uesaka D, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Sasaki M, et al. Evaluation of dual-time-point F-18 FDG PET for staging in patients with lung cancer. J Nucl Med 2008;49:1606-12.
4. Lan XL, Zhang YX, Wu ZJ, Jia Q, Wei H, Gao ZR. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions. Clin Radiol 2008;63:756-64.
5. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-23. (Pubitemid 27260108)
6. Ko JP, Drucker EA, Shepard JA, Mountain CF, Dresler C, Sabloff B, et al. CT depiction of regional node stations for lung cancer staging. AJR Am J Roentgenol 2000;174:775-82. (Pubitemid 30126261)
7. Yen RF, Chen KC, Lee JM, Chang YC, Wang J, Cheng MF, et al. F-18 FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort? Eur J Nucl Med Mol Imaging 2008;35:1305-15.
8. Andreu J, Cceres J, Pallisa E, Martinez-Rodriguez M. Radiological manifestations of pulmonary tuberculosis. Eur J Radiol 2004;51:139-49. (Pubitemid 38916615)
9. Karam M, Roberts-Klein S, Shet N, Chang J, Feustel P. Bilateral hilar foci on F-18 FDG PET scan in patients without lung cancer: Variables associated with benign and malignant etiology. J Nucl Med 2008;49:1429-36.
10. Glazer GM, Gross BH, Quint LE, Francis IR, Bookstein FL, Orringer MB. Normal mediastinal lymph nodes: Number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 1985;144:261-5. (Pubitemid 15168325)
11. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000;30:150-85. (Pubitemid 30469914)
12. Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005;236:1011-9. (Pubitemid 41170866)
13. Kim YK, Lee KS, Kim BT, Choi JY, Kim H, Kwon OJ, et al. Mediastinal nodal staging of nonsmall cell lung cancer using integrated FDG PET/CT in a tuberculosis-endemic country. Cancer 2007;109:1068-77. (Pubitemid 46435384)
14. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. F-18 FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: Consideration of lymph node calcification and distribution pattern to improve specificity. Eur J Nucl Med Mol Imaging 2009;36:1794-802.
15. Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med 2001;28:696-703.